Similar Items: Accelerating African Swine Fever Virus (ASFV) vaccine development via CRISPR-Cas9 and synthetic biology technologies
- Accelerated development of genotype IX African swine fever virus vaccine candidates using rapid CRISPR/Cas9 editing
- Rapid CRISPR/Cas9 editing of genotype IX African swine fever virus circulating in eastern and central Africa
- Evaluation of cross-protection of African swine fever vaccine ASFV-G-ΔI177L between ASFV biotypes
- A synthetic genomics-based African swine fever virus engineering platform
- The African swine fever isolate ASFV-Kenya-IX-1033 is highly virulent and stable after propagation in the wild boar cell line WSL
- Developing vaccines for African swine fever
Author: Abkallo, Hussein M.
- Co-deletion of A238L and EP402R genes from a genotype IX African swine fever virus results in partial attenuation and protection in swine
- Making genome editing a success story in Africa
- High prevalence of Plasmodium malariae and Plasmodium ovale in co-infections with Plasmodium falciparum in asymptomatic malaria parasite carriers in southwestern Nigeria
- Healthy animals for healthy lives in low- and middle-income countries
- The bacterial and pathogenic landscape of African buffalo (Syncerus caffer) whole blood and serum from Kenya
- Deletion of the CD2v gene from the genome of ASFV-Kenya-IX-1033 partially reduces virulence and induces protection in pigs